Skip to main content
FutureChem Co., Ltd. logo

FutureChem Co., Ltd. — Investor Relations & Filings

Ticker · 220100 ISIN · KR7220100002 KO Manufacturing
Open in API
Filings indexed 312 across all filing types
Latest filing 2025-03-07 Audit Report / Informat…
Country KR South Korea
Listing KO 220100

About FutureChem Co., Ltd.

https://www.futurechem.co.kr/?language=…

FutureChem Co., Ltd. is a company specializing in the development and production of radiopharmaceuticals for diagnostic and therapeutic applications. The company's operations cover the manufacturing of radiopharmaceutical precursors, chemical compounds, synthesis reagents, and automated synthesis modules. Its product pipeline focuses on agents for the diagnosis and treatment of various cancers and neurological disorders, including Parkinson's disease. FutureChem supports the broader radiopharmaceutical field by providing both finished products and the essential chemical building blocks and equipment required for their synthesis. The company actively establishes global partnerships for clinical supply and commercial licensing of its technologies.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from the company FutureChem. It provides a summary of financial results, audit opinions, and key financial metrics (assets, liabilities, profit/loss) for the current and previous fiscal years. While it contains financial data, it is a standard regulatory disclosure announcement in Korea (DART/KRX format) notifying the market that the audit report has been submitted, rather than the full, multi-page audited financial statement document itself. Therefore, it falls under the category of a regulatory filing announcement. FY 2024
2025-03-07 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (FutureChem) announcing a significant change in financial results (revenue or profit/loss structure exceeding 30%). This is a standard disclosure requirement in the Korean stock market (KRX) for listed companies to report material financial changes before the final audit report is published. Since it provides key financial highlights and reasons for the change but is not the full annual report, it falls under the 'Earnings Release' category as it serves as the initial announcement of financial performance. FY 2024
2025-02-03 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) system (KIND) regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details an amendment to a previous contract, including changes to the contract period and total contract amount. Since this is a specific regulatory disclosure of a material business contract and does not fit into categories like M&A, financial reports, or shareholder meetings, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous regulatory announcements.
2024-12-26 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) and its subsequent amendment. It details the contract terms, financial values, and counterparty information. Since this is a specific regulatory disclosure of a material business contract and does not fit into categories like earnings releases, annual reports, or board changes, it falls under the general regulatory filing category.
2024-12-24 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement from FutureChem regarding the setting of a record date and shareholder register closure period for the purpose of holding an upcoming Annual General Meeting. It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of the procedural steps for the meeting. Given it is a regulatory announcement regarding meeting logistics, it fits best under the RNS category.
2024-12-12 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'FutureChem' (주식회사 퓨쳐켐) covering the period from January 1, 2024, to September 30, 2024. It contains detailed financial information, company overview, capital changes, and management details, which is characteristic of a comprehensive interim financial report. It is not an announcement of a report, but the report itself. 9M 2024
2024-11-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.